
|Videos|January 13, 2022
Mirvie RNA test aims to predict pregnancy complications
Author(s)Morgan Ebert, Managing Editor
Maneesh Jain, CEO and co-founder of Mirvie, a proprietary RNA platform that uses blood samples to predict pregnancy complications such as preeclampsia, sits down with Contemporary OB/GYN to discuss the potential of the test.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Research suggests increasing labor induction prior to 39 weeks
2
Cervical cancer screening FAQs: Key updates from HRSA-supported guidelines
3
Thin evidence base for smartphone apps targeting perinatal mental health
4
American Heart Association releases scientific statement for maternal stroke prevention during pregnancy, postpartum
5









